Abstract
Obesity is supposed to cause renal injury via autophagy deficiency. Recently, sodium glucose co-transporter 2 inhibitors (SGLT2i) were reported to protect renal injury. However, the mechanisms of SGLT2i for renal protection are unclear. Here, we investigated the effect of SGLT2i for autophagy in renal proximal tubular cells (PTCs) on obesity mice. We fed C57BL/6J mice with a normal diet (ND) or high-fat and -sugar diet (HFSD) for nine weeks, then administered SGLT2i, empagliflozin, or control compound for one week. Each group contained N = 5. The urinary N-acetyl-beta-d-glucosaminidase level in the HFSD group significantly increased compared to ND group. The tubular damage was suppressed in the SGLT2i-HFSD group. In electron microscopic analysis, multi lamellar bodies that increased in autophagy deficiency were increased in PTCs in the HFSD group but significantly suppressed in the SGLT2i group. The autophagosomes of damaged mitochondria in PTCs in the HFSD group frequently appeared in the SGLT2i group. p62 accumulations in PTCs were significantly increased in HFSD group but significantly suppressed by SGLT2i. In addition, the mammalian target of rapamycin was activated in the HFSD group but significantly suppressed in SGLT2i g...Continue Reading
References
Mar 16, 2004·Pediatric Diabetes·Mona A K SalemPerihan H Tawfik
Apr 17, 2004·Kidney International·Kunitoshi IsekiShuichi Takishita
Feb 1, 2006·Clinical and Experimental Pharmacology & Physiology·Faruk OktemBumin Dündar
Oct 13, 2006·Journal of the American Society of Nephrology : JASN·Mauro AbbateGiuseppe Remuzzi
Feb 27, 2009·Cancer Research·Jeremy CoppTony Hunter
Aug 12, 2010·Methods in Molecular Biology·Isei Tanida, Satoshi Waguri
Jan 14, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Volker Vallon
May 14, 2011·Autophagy·Eeva-Liisa EskelinenPer O Seglen
Dec 18, 2013·Circulation·David Z I CherneyMaximilian von Eynatten
Jun 27, 2015·Experimental Cell Research·Hui WangWei Liu
Nov 5, 2015·Advances in Therapy·Nobuya InagakiHiroaki Iijima
Mar 30, 2016·Diabetologia·Munehiro KitadaDaisuke Koya
Jun 7, 2016·Nature Reviews. Nephrology·Vivette D D'AgatiManuel Praga
Jun 15, 2016·The New England Journal of Medicine·Christoph WannerUNKNOWN EMPA-REG OUTCOME Investigators
Dec 10, 2016·Journal of the American Society of Nephrology : JASN·Takeshi YamamotoYoshitaka Isaka
Feb 24, 2017·Biochimie·Giovani B PeresYara M Michelacci
Jun 9, 2017·Current Diabetes Reports·Munehiro KitadaDaisuke Koya
Sep 14, 2017·Npj Aging and Mechanisms of Disease·Taichi SugizakiYuichi Oike
Jan 6, 2018·International Journal of Molecular Sciences·Dong WangMoshe Levi
Jan 21, 2018·Journal of Diabetes Investigation·Susumu TakagiDaisuke Koya
Mar 7, 2018·Scientific Reports·Michitsugu KamezakiKeiichi Tamagaki
May 3, 2018·Scientific Reports·Hiroyuki UminoHiroshi Itoh
Jul 20, 2018·Kidney International·Shinji TanakaTetsuhiro Tanaka
Aug 4, 2018·The Journal of Pathology·Elena RampanelliJaklien C Leemans
Sep 22, 2019·Cells·Wen-Chin LeeJin-Bor Chen
Apr 29, 2020·International Journal of Molecular Sciences·Anton I KorbutVadim V Klimontov
Citations
Apr 16, 2021·Endocrinology·Caroline W S Hoong, Marvin W J Chua
Sep 12, 2021·Nature Reviews. Endocrinology·Munehiro Kitada, Daisuke Koya
Jan 13, 2022·Expert Review of Clinical Pharmacology·Saurabh NayakKamal Kant Sahu